All SEC Filings :: Syros Pharmaceuticals, Inc. (SYRS)

Filing Type:

Year:

Date	Form	Description	Pages
09/19/22	3	Initial statement of beneficial ownership of securities Documents EX-24	2
09/19/22	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	8
09/19/22	S-4MEF	A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-4 Documents EX-5.1 EX-23.2 EX-23.3 EX-FILING FEES	10
09/16/22	SC 13D/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities	4
09/16/22	8-K	Current report filing Documents EX-3.1 EX-3.2 EX-99.1	15
09/16/22	S-8	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Documents EX-5.1 EX-23.2 EX-FILING FEES	12
09/15/22	425	Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions	22
09/15/22	8-K	Current report filing Documents EX-99.1 EX-99.2	22
09/02/22	425	Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions	18
09/02/22	8-K	Current report filing	18